Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

Author:

Tobin Joshua W. D.1,Rule Gabrielle2,Colvin Katherine2,Calvente Lourdes3,Hodgson David3,Bell Stephen4,Dunduru Chengetai5,Gallo James6,Tsang Erica S.7,Tan Xuan8,Wong Jonathan9ORCID,Pearce Jessica10,Campbell Robert11,Tneh Shao12,Shorten Sophie13,Ng Melissa14,Cochrane Tara14,Tam Constantine S.13,Abro Emad12,Hawkes Eliza11ORCID,Hodges Georgina10,Kansara Roopesh15,Talaulikar Dipti16,Gilbertson Michael9,Johnston Anna M.8,Savage Kerry J.7,Villa Diego7ORCID,Morris Kirk6,Ratnasingam Sumi5,Janowski Wojt4,Kridel Robert3ORCID,Cheah Chan Y.2,MacManus Michael17ORCID,Matigian Nicholas18ORCID,Mollee Peter1,Gandhi Maher K.1ORCID,Hapgood Greg1

Affiliation:

1. Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;

2. Department of Haematology, Sir Charles Gairdner Hospital, Perth, WA, Australia;

3. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada;

4. Department of Haematology, Calvary Mater Health, Newcastle, NSW, Australia;

5. Department of Haematology, Andrew Love Cancer Centre, University Hospital Geelong, Geelong, VIC, Australia;

6. Department of Haematology, Royal Brisbane Hospital, Brisbane, QLD, Australia;

7. Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada;

8. Department of Haematology, Royal Hobart Hospital, Hobart, TAS, Australia;

9. Department of Clinical Haematology, Monash Health, Melbourne, Victoria, Australia,

10. Department of Haematology, Townsville Hospital, Townsville, QLD, Australia;

11. Department of Oncology and Clinical Haematology, Austin Hospital, Melbourne, VIC, Australia;

12. Department of Haematology, Mater Hospital Brisbane, Brisbane, QLD, Australia;

13. Department of Haematology, St Vincent’s Hospital, Melbourne, VIC, Australia;

14. Department of Haematology, Gold Coast University Hospital, Gold Coast, QLD, Australia;

15. Section of Medical Oncology and Haematology, University of Manitoba, Winnipeg, MB, Canada;

16. Department of Haematology, Canberra Hospital, Canberra, ACT, Australia;

17. Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; and

18. QFAB Bioinformatics, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia

Abstract

Key PointsPractices in early-stage FL are variable and include radiation alone, systemic therapy, CMT, or observation. Each practice resulted in similar excellent outcomes; randomized trials are required to determine the optimal treatment.

Publisher

American Society of Hematology

Subject

Hematology

Reference30 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3